Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522535 | SCV000618834 | uncertain significance | not provided | 2017-07-07 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the ZEB2 gene. The M824T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The M824T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The M824T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position where amino acids with similar properties to Methionine are tolerated across species. Additionally, missense variants in the ZEB2 gene are rare and have been identified in less than 2% of patients with Mowat-Wilson syndrome (Garavelli et al., 2009). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV000544719 | SCV000641873 | benign | Mowat-Wilson syndrome | 2023-05-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000544719 | SCV002045624 | uncertain significance | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000544719 | SCV002815805 | uncertain significance | Mowat-Wilson syndrome | 2022-03-31 | criteria provided, single submitter | clinical testing |